126
Views
52
CrossRef citations to date
0
Altmetric
Paper

Proliferation and micromilieu during fractionated irradiation of human FaDu squamous cell carcinoma in nude mice

, , , , , & show all
Pages 469-477 | Received 02 Dec 2002, Accepted 22 May 2003, Published online: 03 Jul 2009

References

  • ALLAM, A., PEREZ, L. A., HUANG, P., TAM-HAN, A., AZINOVIC, I., FREEMAN, J., DUFFY, M., EFIRD, J. and Sun, H. D., 1995, The effect of the overall treatment time of fractionated irradiation on the tumor control probability of a human soft tissue sarcoma xenograft in nude mice. International Journal of Radiation, Oncology, Biology and Physics, 32, 105–111.
  • BAUMANN, M., DUBOIS, W. and SUIT, H. D., 1990, Response of human squamous cell carcinoma xenografts of different sizes to irradiation: relationship of clonogenic cells, cellular radiation sensitivity in vivo, and tumor rescuing units. Radiation Research, 123, 325–330.
  • BAUMANN, M., LLERTZ, C., BAISCH, H., WIEGEL, T., LORENZEN, J. and ARPS, H., 1994, Impact of overall treatment time of fractionated irradiation on local control of human FaDu squamous cell carcinoma in nude mice. Radiotherapy and Oncology, 32, 137–143.
  • BAUMANN, M., PETERSEN, C., ScuuLz, P. and BAISC HH., 1999, Impact of overall treatment time on local control of slow growing human GL squamous cell carcinoma in nude mice treated by fractionated irradiation. Radiotherapy and Oncology, 50, 107–111.
  • BECK-BORNHOLDT, H. P., OMNICZYNSKI, M., THEIS, E., VOGLER, H. and WURSCHMIDT, F., 1991, Influence of treatment time on the response of rat rhabdomyosarcoma R1H to fractionated irradiation. Acta Oncologica, 30, 57–63.
  • BouRms, J., 2000, Very accelerated radiotherapy in advanced HNSCC: results of the GORTEC 94–02 randomized trial. Radiotherapy and Oncology, 56 (Suppl. 1), S4.
  • BOWERS, G., REARDON, D., HEWITT, T., DENT, P., MIKKELSEN, R. B., VALERIE, K., LAMMERING, G., Amm, C. and SCHMIDT-ULLRICH, R. K., 2001, The relative role of ErbB1-4 receptor tyrosine kinases in radiation signal transduction responses of human carcinoma cells. Oncogene, 20, 1388–1397.
  • DISCHE, S., SAUNDERS, M., BARRETr, A., HARVEY, A., GIBSON, D. and PARMAR, M., 1997, A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer. Radiotherapy and Oncology, 44, 123–136.
  • EICHELER, W., Zips, D., DORFLER, A., GRENMAN, R. and BAUMANN, M., 2002, Splicing mutations in TP53 in human squamous cell carcinoma lines influence immunohistochemical detection. Journal of Histochemistry and Cytochemistry, 50, 197–204.
  • FOWLER, J. F., 1991, Rapid repopulation in radiotherapy: a debate on mechanism. The phantom of tumor treatment continually rapid proliferation unmasked. Radiotherapy and Oncology, 22, 156–158.
  • Fu, K. K., PAJAK, T. F., TRoTrr, A., JONES, C. U., SPENCER, S. A., PHILLIPS, T. L., GARDEN, A. S., RIDGE, J. A., COOPER, J. S. and ANG, K. K., 2000, A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. International Journal of Radiation, Oncology, Biology and Physics, 48, 7–16.
  • HESSEL, F., PETERSEN, C., ZIPS, D., KRAUSE, M., PFITZMANN, D., THAMES, H. and BAUMANN, M., 2003, Impact of increased cell loss on repopulation rate during fractionated irradiation in human FaDu squamous cell carcinoma growing in nude mice. International journal of Radiation Biology, 79, 479–486.
  • HORIOT, J. C., BONTEMPS, P., VAN DEN BOGAERT, W., LE FUR, R., VAN DEN WEIJNGAERT, D., BOLLA, M., BERNIER, J., LUSINCHI, A., STUSCHKE, M., LOPEZ-TORRECILLA, J., BEGG, A. C., PIERART, M. and COTJYTIT, L., 1997, Accelerated fractionation (AF) compared to conventional fractiona-tion (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial. Radiotherapy and Oncology, 44, 111–121.
  • HUANG, S. M., BOCK, J. M. and HARARI, P. M., 1999, Epidermal growth factor receptor blockade with C225 modulates proliferation, apoptosis, and racliosensitivity in squamous cell carcinomas of the head and neck. Cancer Research, 59, 1935–1940.
  • MENDONCA, M. S., RODRIGUEZ, A. and ALPEN, E. L., 1990, Differential repair of potentially lethal damage in exponentially growing and quiescent 9L cells. Radiation Research, 122, 38–43.
  • MILAS, L., 2000, Epidermal growth factor and its receptor in tumor response to radiation. In H. J. Feldmann, P. Kneschaurek and M. Molls (eds), Three-dimensional Radiation Treatment. Technological Innovations and Clinical Results (Basel: Karger).
  • OVERGAARD, J., 2000, The DAHANCA 6 & 7 trial. A rando-mized multicenter study of 5 versus 6 fractions per week of conventional radiotherapy of squamous cell carcinoma of the head and neck. Radiotherapy and Oncology, 56 (Suppl. 1), S4.
  • PETERSEN, C., ZIPS, D., KRAUSE, M., SCHONE, K., EICHELER, W., HOINKIS, C., THAMES, H. D. and BAUMANN, M., 2001, Repopulation of FaDu human squamous cell carcinoma during fractionated radiotherapy correlates with reoxygen-ation. International Journal of Radiation, Oncology, Biology and Physics, 51, 483–493.
  • ROSNER, B., 1990, Fundamentals of Biostatistics, 4th edn (Duxbury).
  • SAUNDERS, M., DISCHE, S., BARRETT, A., HARVEY, A., GRIFFITHS, G. and PALMAR, M., 1999, Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial. Radiotherapy and Oncology, 52, 137–148.
  • SCHMIDT-ULLRICH, R. K., CONTESSA, J. N., DENT, P., MIKKELSEN, R. B., VALERIE, K., REARDON, D. B., BOWERS, G. and LIN, P. S., 1999, Molecular mechanisms of radiation-induced accelerated repopulation. Radiation Oncology Investigation, 7, 321–330.
  • SCHMTDT-ULLRICH, R. K., MIKKELSEN, R. B., DENT, P., TODD, D. G., VALERIE, K., KAVANAGH, B. D., CONTESSA, J. N., ROARER, W. K. and CHEN, P. B., 1997, Radiation-induced proliferation of the human A431 squamous carcinoma cells is dependent on EGFR tyrosine phosphorylation. Oncogene, 15, 1191–1197.
  • SCHMIDT-ULLRICH, R. K., VALERIE, K., FOGLEMAN, P. B. and WALTERS, J., 1996, Radiation-induced autophosphory-lation of epidermal growth factor receptor in human malignant mammary and squamous epithelial cells. Radiation Research, 145, 81–85.
  • SKLADOWSKI, K., MAClEJEWSKI, B., GOLEN, M., PILECKI, B., PRZEOREK, W. and TARNAWSKI, R., 2000, Randomized clinical trial on 7-day-continuous accelerated irradiation (CAIR) of head and neck cancerreport on 3-year tumour control and normal tissue toxicity. Radiotherapy and Oncology, 55, 101–110.
  • SPEKE, A. K. and HILL, R. P., 1995, Repopulation kinetics during fractionated irradiation and the relationship to the potential doubling time, Tpot. International Journal of Radiation, Oncology, Biology and Physics, 31, 847–856.
  • TURIUSI, A. T., III., Km, K., BLum, R., SAusE, W. T., LIVINGSTON, R. B., KOMAKI, R., WAGNER, H., AISNER, S. and JOHNSON, D. H., 1999, Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. New England Journal of Medicine, 340, 265–271.
  • ZIETMAN, A. L., Sun, H. D., RAMSAY, J. R., S1LOBRCIC, V. and SEDLACEK, R. S., 1988, Quantitative studies on the transplantability of murine and human tumors into the brain and subcutaneous tissues of NCr/Sed nude mice. Cancer Research, 48, 6510–6516.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.